United Biomedical Inc.

2020-02/26

UBI 集團科研能量將攻堅新冠肺炎病毒帶來的人類大災難
2019-11/26

United BioPharma Signs clinical trial agreement with NIH/NIAID for sponsorship of a multi-drug resistant HIV trial with UB-421
2019-10/06

PharmaBoardRoom interview of Dr. Chang Yi Wang, Chairperson and Chief Scientific Officer of United Biopharma (UBP)
2019-11/08

United BioPharma Receives US FDA Approval for UB-221 Phase 1 IND for Chronic Spontaneous Urticaria
2019-04/18

United Biomedical Announces Publication of Breakthrough HIV Clinical Trial Data in the New England Journal of Medicine
2019-05/21

United Biopharma obtains approval from the U.S. FDA to conduct a clinical trial with UB-421 in Patients with Multi-Drug Resistance HIV-1 infection
2019-06/11

United BioPharma Receives US FDA Approval for UB-621 Phase 2 Trial in Recurrent Genital Herpes Patients
2019-09/02

United BioPharma successfully completes Taiwan FDA GMP inspection for its 2000L commercial scale manufacturing facility

United Biomedical, Inc.

We are an entrepreneurial biopharmaceutical company committed to delivering life-changing solutions to improve global health. We dedicate our scientific rigor to maintaining an innovation-driven, patient-oriented culture with outstanding execution and continuous improvement to fight diseases and improve medical interventions with unmet need.

News and Events

Press Releases and Media Coverage

2019/07/20

A vaccine for Alzheimer’s is on the verge of becoming a reality
2019/06/06

Is an Alzheimer’s Cure on the Horizon?
2019/06/11

United BioPharma Receives US FDA Approval for UB-621 Phase 2 Trial in Recurrent Genital Herpes Patients